Ask PAM anything about private markets: valuations, sector comparisons, and how tender offers work.Get the iOS appAsk PAM anything about private markets.Get the iOS app

Freenome IPO

Health technology company using non-invasive disease screenings to treat diseases.

NASDAQ:FRNM

Buy

Buy Private Stock

Sign up to invest in private companies like Freenome before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Freenome before their IPO.

Overview

Freenome completed their IPO on July 21, 2026. Now that Freenome is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.

Freenome is a health technology company using accurate, accessible and non-invasive disease screenings to proactively treat cancer and other diseases at their most manageable stages. Freenome does this through a fusion of machine learning, biology and computer science.

Sector

Healthcare & Life Sciences

Founded

2016

Headquarters

South San Francisco, CA

Freenome Funding

Freenome Funding History Pre-IPO

Gain insights into Freenome funding history prior to their IPO, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series F Feb 15, 2024 254M
XXXXX
XXXXX
Series E Jan 11, 2022 290M
XXXXX
XXXXX
Series D Nov 22, 2021 243M
XXXXX
XXXXX
Series C Aug 14, 2020 270M
XXXXX
XXXXX
Series B Jun 24, 2019 160M
XXXXX
XXXXX
Series A Aug 14, 2017 8M
XXXXX
XXXXX
Series A Feb 23, 2017 64M
XXXXX
XXXXX
Series Seed-2 May 23, 2016 6M
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Private Stock

Sign up to invest in private companies like Freenome before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Freenome before their IPO.

Freenome Management Team

Freenome people and management – Prior to IPO

  • Co-Founder, CPO
    Riley Ennis
  • CEO, Board Member
    Aaron Elliott
  • CFO
    Linh H. Le
  • Board Member
    Ann Costello
  • Board Member
    Carole Nuechterlein
  • Board Member
    Deepa Pakianathan
  • Board Member
    Douglas VanOort
  • Board Member
    Ellen Hukkelhoven
  • Board Member
    Peter Kolchinsky
  • Board Member
    Randal Scott
  • Chief People Officer
    Julie Tran
  • Chief Scientific Officer
    Jimmy Lin

Investors

Major Freenome investors

  • Andreessen Horowitz

  • Ark Investments

  • Arrowmark Partners

  • Artis Ventures

  • Asset Management Ventures

  • Bain Capital

  • BrightEdge

  • Brightedge Ventures

  • Catalio Capital Management, LP

  • Charles River Ventures (CRV)

  • Colorectal Cancer Alliance

  • Cormorant Asset Management

  • Cormorant Capital

  • Data Collective

  • Dcvc

  • DCVC

  • EcoR1 Capital

  • Eventide Asset Management Llc

  • Farallon Capital Management LLC

  • F. Hoffmann-La Roche AG

  • Fidelity Management and Research Co.

  • Founders Fund

  • Global Venture Capital, Inc.

  • Google Ventures

  • Innovation Endeavors

  • Intermountain Ventures

  • Janus Henderson

  • Kaiser Permanente Ventures

  • Novartis, Inc.

  • Perceptive Advisors

  • Perceptive Advisors, LLC

  • Polaris Partners

  • Pura Vida Investments

  • Quest Diagnostics

  • RA Capital Management

  • Ridgeback Capital

  • Roche

  • Roche Venture Fund

  • Rock Springs Capital

  • Sands Capital

  • Sands Capital Management LLC

  • Section 32

  • Soleus Capital Management

  • Spectrum 28 Capital

  • Squarepoint Capital

  • Third Kind Venture Capital

  • T. Rowe Price Associates, Inc.

  • Verily Life Sciences LLC

Freenome Valuations & Financials

Looking for private company valuations and share price data?

Nasdaq Private Market Data & Intelligence is the private company valuation database covering 4,000+ venture-backed companies with daily pricing, financing history, and secondary market activity. View real-time NPM data on pre-IPO companies including valuations, private company comparable transactions, and historical share price information — the private company due diligence data sources institutional investors rely on.

Similar Companies

Explore companies

like Freenome

  • Noom Inc-Logo

    Noom

    Healthcare & Life Sciences

    Intelligent weight loss app.

  • Swordhealth-Logo

    Sword Health

    Healthcare & Life Sciences

    Virtual musculoskeletal care provider.

  • Rakuten Medical-Logo

    Rakuten Medical

    Healthcare & Life Sciences

    Develops targeted cancer treatments using photoimmunotherapy technology to create more effective and accessible therapeutic solutions.

  • BillionToOne

    Healthcare & Life Sciences

    Developed a DNA molecular counting technology for detecting gene disorders through a blood test.

  • workit health logo

    Workit Health

    Healthcare & Life Sciences

    Provider of clinically proven telemedicine treatment for substance use disorder.

  • Judi Health

    Healthcare & Life Sciences

    Healthcare technology company that manages pharmacy benefits.

  • TripleBar

    Healthcare & Life Sciences

    Creates products that nourish, heal, and sustain both people and the planet.

  • Hone Health

    Healthcare & Life Sciences

    Online clinic specializing in preventative and proactive longevity care.

  • Clear Labs

    Healthcare & Life Sciences

    Pioneers in food analytics, enabling brands to differentiate on quality and ensure value.

FAQ

Questions?

We have answers

Buy Freenome Stock

Freenome became publicly traded following its IPO on July 21, 2026, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: FRNM. Before the IPO, Freenome stock was privately held and available only through private market transactions.

If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.

Sell Freenome Stock

Following its IPO on July 21, 2026, Freenome shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.

If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.

 

Freenome Stock Price

Following the IPO, Freenome stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching Freenome’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.

Freenome Stock Ticker Symbol

Following its IPO on July 21, 2026, Freenome stock now trades on public markets under the ticker symbol NASDAQ: FRNM. You can view real-time stock information through widely used financial data platforms.

Criteria to Sell Freenome Stock

Following the Freenome IPO, public shares can be sold through any brokerage.

Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Freenome Stock

Following Freenome’s initial public offering on July 21, 2026, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying Freenome stock can do so through their preferred broker, just as they would with any other publicly traded security.

Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Freenome Stock Settlement

Since Freenome is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.

Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Freenome IPO

Freenome completed its IPO on July 21, 2026, and is now publicly available through major financial sources.